Immune System -- Tumor Efficiency Rate as a new Oncological Index for Radiotherapy Treatment Optimization

dc.creatorSotolongo-Grau, O.
dc.creatorRodriguez-Perez, D.
dc.creatorSantos-Miranda, J. A.
dc.creatorSotolongo-Costa, O.
dc.creatorAntoranz, J. C.
dc.date2007-06-04
dc.date2007-06-28
dc.date.accessioned2026-07-07T08:12:34Z
dc.date.available2026-07-07T08:12:34Z
dc.descriptionA dynamical system model for tumor -- immune system interaction together with a method to mimic radiation therapy are proposed. A large population of virtual patients is simulated following an ideal radiation treatment. A characteristic parameter, the Immune System -- Tumor Efficiency Rate (ISTER), is introduced. ISTER dependence of treatment success and other features is studied. Statistical results allow us to give a patient classification scheme. Radiotherapy treatment biological effective dose (BED) is thus optimized based on the patient physical condition, following the ALARA (As Low As Reasonably Achievable) criterion.
dc.description10 pages, 3 figures
dc.identifierhttps://arxiv.org/abs/0706.0418
dc.identifierhttp://arxiv.org/abs/0706.0418
dc.identifier.urihttp://salesiana.dossiersoluciones.com/handle/123456789/132498
dc.subjectPopulations and Evolution
dc.titleImmune System -- Tumor Efficiency Rate as a new Oncological Index for Radiotherapy Treatment Optimization
dc.typetext

Files

Collections